FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely venlafaxine (as venlafaxine hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely pilocarpine hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely seratrodast 80 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely dicycloverine hydrochloride 10 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely citicoline (as citicoline sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely citicoline (as citicoline sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram and fenofibrate 160 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram and fenofibrate 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely atorvastatin (as atorvastatin calcium) 10 milligram and fenofibrate 160 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely hydrochlorothiazide 12.5 milligram and nebivolol (as nebivolol hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely piroxicam 20 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely carbinoxamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely carbinoxamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely naproxen (as naproxen sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely naproxen (as naproxen sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely metformin hydrochloride 500 milligram and voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely metformin hydrochloride 500 milligram and voglibose 200 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely flavoxate hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely flavoxate hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlordiazepoxide 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely chlordiazepoxide 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely chlordiazepoxide 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely etofylline 77 milligram and theophylline anhydrous 23 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 2
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1
Product containing precisely lamotrigine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit True Tablet Inferred relationship Existential restriction modifier 1

Start Previous Page 79 of 153 Next End

This concept is not in any reference sets

Back to Start